Enovix is trading at $2.81, +10.00%, with no verified October 23 announcement clearly explaining the gain. - The October 22 filing clarified that reported 2027 revenue estimates were not company-authorized guidance. - Enovix is rebounding after recent volatility, but coverage does not establish the clarification or earlier drone-order news as a fresh session catalyst. - Technology was reported lower and major indexes were mixed; no volume information was provided.